Clinical Trial Update: Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing Arimidex (anastrozole) and tamoxifen in premenopausal women with breast cancer under anti-hormonal treatment; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-09-06